HIGHLIGHTS
- who: Yoshiki Higa and collaborators from the Department of Orthodontics and Dentofacial Orthopedics, Graduate School of Biomedical, Tokushima University, Kuramoto, Tokushima, Japan have published the article: The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2, in the Journal: Antioxidants 2022, 11, x FOR PEER REVIEW of 20/Dec/2022
- what: The authors demonstrate that a alleviates increase in adipose tissue mass in obese mouse models with a high-fat diet or ovariectomy. disrupts in vitro adipocytic differentiation in adipogenic media. The authors explored the effects of febuxostat on adipocyte differentiation by focusing on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.